Skip to main content

Barclays Sticks to Its Hold Rating for DR Horton (DHI)

Tipranks - Tipranks - Thu Jan 22, 1:36AM CST

Barclays analyst Matthew Bouley maintained a Hold rating on DR Horton today and set a price target of $129.00.

Claim 50% Off TipRanks Premium

According to TipRanks, Bouley is a 5-star analyst with an average return of 15.2% and a 63.27% success rate. Bouley covers the Industrials sector, focusing on stocks such as Fortune Brands Innovations, Builders Firstsource, and Advanced Drainage Systems.

In addition to Barclays, DR Horton also received a Hold from TipRanks – Anthropic’s Anthropic Residential Construction in a report issued yesterday. However, on the same day, TipRanks – OpenAI reiterated a Buy rating on DR Horton (NYSE: DHI).

See today’s best-performing stocks on TipRanks >>

Based on DR Horton’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $9.68 billion and a net profit of $905.3 million. In comparison, last year the company earned a revenue of $10 billion and had a net profit of $1.28 billion

Read More on DHI:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).